Related Experiment Videos
Drug therapy for hyperlipidemia. When reducing cardiovascular risk is a priority
1Lipid Center, Humana Heart Institute International, Louisville, KY 40217.
Postgraduate Medicine
|April 1, 1992
Summary
Physicians can stay updated on lipid-lowering agents with this review. It covers major antihyperlipidemics, patient selection, and cost-effectiveness for managing high cholesterol.
Area of Science:
- Cardiology
- Pharmacology
Background:
- The field of lipid-lowering agents is rapidly evolving.
- Keeping abreast of the latest research is challenging for busy clinicians.
Purpose of the Study:
- To provide an update on major antihyperlipidemic medications.
- To guide patient selection for lipid-lowering therapy.
- To discuss the cost-effectiveness of various treatment options.
Main Methods:
- Review of current literature on antihyperlipidemic agents.
- Analysis of patient profiles for optimal therapy selection.
- Comparative assessment of cost-effectiveness.
Main Results:
- Overview of currently available major lipid-lowering drugs.
- Guidance on identifying appropriate candidates for therapy.
- Evaluation of economic factors influencing treatment choices.
Conclusions:
- This review offers a practical update for clinicians managing dyslipidemia.
- Informed patient selection and cost-effectiveness analysis are crucial for optimal antihyperlipidemic therapy.